US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

del Nido Cardioplegia Solution

Reason Lack of Assurance of Sterility; bags have potential to leak

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center D-0151-2020
Class II · Moderate risk Terminated

Amino Acid Injection 50 g/1000 mL

Reason Lack of Assurance of Sterility; bags have potential to leak

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center D-0150-2020
Class II · Moderate risk Terminated

PF-Fentanyl Citrate

Reason GMP Deviations: potential glass contamination

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-0525-25 D-0147-2020
Class II · Moderate risk Terminated

Leucovorin Calcium Injection

Reason Crystallization: Presence of particulate matter identified as API crystallization

Ingenus Pharmaceuticals Llc NDC 50742-464-50 D-0146-2020
Class II · Moderate risk Terminated

Rifampin for Injection

Reason Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.

Mylan Laboratories Limited (Sterile Products Division) NDC 67457-445-60 D-0139-2020
Class II · Moderate risk Terminated

Children's Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 67091-321-04 D-0302-2020
Class II · Moderate risk Terminated

Children's Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-2130-1 D-0301-2020
Class II · Moderate risk Terminated

Children's Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-2130-8 D-0300-2020
Class II · Moderate risk Terminated

Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-9 D-0299-2020
Class II · Moderate risk Terminated

Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-8 D-0298-2020
Class II · Moderate risk Terminated

Estradiol tablets

Reason Presence of Foreign Tablets/Capsules: Estradiol 1 mg was found in a 100 count bottle of Estradiol 0.5 mg Tablets.

Epic Pharma, LLC NDC 42806-087-01 D-0135-2020
Class II · Moderate risk Terminated

Vivitrol

Reason Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.

Alkermes, Inc. D-0119-2020
Class II · Moderate risk Terminated

DrKids Himasal Natural Nasal Saline Solution

Reason CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.

Unipharma, Llc. D-0133-2020
Class II · Moderate risk Terminated

Prednisolone Sodium Phosphate Oral Solution

Reason Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14

Morton Grove Pharmaceuticals, Inc. NDC 60432-212-08 D-0130-2020
Class II · Moderate risk Terminated

Phenylephrine Hydrochloride Ophthalmic Solution

Reason Lack of Assurance of Sterility: Out of specification results for container closure test which cannot guarantee the sterility of the product.

Akorn, Inc. NDC 17478-201-15 D-1883-2019